undefined

Liran Belenzon

Co-founder and CEO of BenchSci, a leading AI solutions provider for preclinical R&D in the life sciences sector. Expert in applying AI to improve drug discovery and R&D workflows.

Best podcasts with Liran Belenzon

Ranked by the Snipd community
undefined
Feb 26, 2025 • 19min

Understanding AI’s Expanding Role in Drug Discovery and Life Sciences R&D - Liran Belenzon of BenchSci

Liran Belenzon, Co-founder and CEO of BenchSci, is a trailblazer in applying AI to drug discovery and R&D. He discusses how AI transformations are tackling the complexities of disease biology, paving the way for more efficient workflows. Liran highlights the significance of knowledge graphs and multimodal AI in enhancing research speed and quality. He emphasizes the need for flexible drug discovery processes and the importance of adapting budgets to harness AI’s full potential, balancing innovation with cost-effectiveness.